Fundz

Foghorn Therapeutics Appoints Ryan Maynard as Chief Financial Officer

PUBLIC · FHTXFeb 23, 2026

Position

Chief Financial Officer

Company

Foghorn Therapeutics

Ryan Maynard
CambridgeBiotechnologyHealth CareTherapeutics

Description

Foghorn® Therapeutics Inc. announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026. Mr

Quick answer

Foghorn Therapeutics Appoints Ryan Maynard as Chief Financial Officer (February 23, 2026). Foghorn Therapeutics is based in Cambridge, Maryland, United States.

Who is the new Chief Financial Officer at Foghorn Therapeutics?
Foghorn Therapeutics named Ryan Maynard Chief Financial Officer, announced February 23, 2026.
What did Foghorn Therapeutics announce on February 23, 2026?
Foghorn® Therapeutics Inc. announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026.
What does Foghorn Therapeutics do?
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system.
Where is Foghorn Therapeutics based?
Foghorn Therapeutics is based in Cambridge, Maryland, United States.
Which similar companies made leadership changes around the same time?
XenoSTART (February 24, 2026), Kenai Therapeutics (February 24, 2026), Insitro (February 26, 2026) and Pulse Biosciences, Inc. (February 27, 2026) also announced leadership changes within 45 days of Foghorn Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Foghorn Therapeutics, and when

A new leader at Foghorn Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Foghorn Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Foghorn Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Foghorn Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Foghorn Therapeutics

Location

Cambridge, Maryland, United States

About

Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary, scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying, and validating potential drug targets within the chromatin regulatory system. The Company is developing multiple product candidates in oncology. Visit our website at www.foghorntx.com for more information on the Company, and follow us on X (formerly Twitter) and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Foghorn Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Foghorn Therapeutics's next move

Learn about Strategic plan

Foghorn Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.